The Bath Ankylosing Spondylitis Patient Global Score (BAS-G).
about
Internet-based randomised controlled trials for the evaluation of complementary and alternative medicines: probiotics in spondyloarthropathyReport of 12 cases of ankylosing spondylitis patients treated with Tripterygium wilfordiiIdentification of RGS1 as a candidate biomarker for undifferentiated spondylarthritis by genome-wide expression profiling and real-time polymerase chain reaction.Combined home exercise is more effective than range-of-motion home exercise in patients with ankylosing spondylitis: a randomized controlled trial.The information needs of people living with ankylosing spondylitis: a questionnaire survey.Effects of glossopharyngeal insufflation in ankylosing spondylitis: a pilot studyPsychometric characteristics of the short form 36 health survey and functional assessment of chronic illness Therapy-Fatigue subscale for patients with ankylosing spondylitis.Withdrawal from labour force due to work disability in patients with ankylosing spondylitis.Employment, work disability, and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patientsEmployment perspectives of patients with ankylosing spondylitis.Health status of patients with ankylosing spondylitis: a comparison with the general population.Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis.Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitisThe British Society for Rheumatology Biologics Registers in Ankylosing Spondylitis (BSRBR-AS) study: Protocol for a prospective cohort study of the long-term safety and quality of life outcomes of biologic treatment.Development of a health index in patients with ankylosing spondylitis (ASAS HI): final result of a global initiative based on the ICF guided by ASAS.Osteoporosis in ankylosing spondylitis - prevalence, risk factors and methods of assessment.Health-related Quality of Life Assessment on 100 Tunisian Patients with Ankylosing Spondylitis using the SF-36 Survey.Cardiac Autonomic Function in Patients With Ankylosing Spondylitis: A Case-Control StudyInfliximab dose reduction sustains the clinical treatment effect in active HLAB27 positive ankylosing spondylitis: a two-year pilot study.rs657075 (CSF2) Is Associated with the Disease Phenotype (BAS-G) of Ankylosing SpondylitisMeasures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath AnkylosVariables related to work productivity loss in patients with ankylosing spondylitis.Valuing treatment with infliximab for ankylosing spondylitis using a willingness-to-pay approach.Functional limitation and associated factors in outpatients with ankylosing spondylitis in Southwest China.Role of matrix metalloproteinase-3 (MMP-3) and magnetic resonance imaging of sacroiliitis in assessing disease activity in ankylosing spondylitis.Registry of the clinical characteristics of spondyloarthritis in a cohort of Egyptian population.Living with Ankylosing Spondylitis: the patient's perspective.Patient-physician discordance in global assessment in early spondyloarthritis and its change over time: the DESIR cohort.Gender-attributable differences in outcome of ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study.Sexual dysfunctions and lower urinary tract symptoms in ankylosing spondylitis.The clinical usefulness of ESR, CRP, and disease duration in ankylosing spondylitis: the product of these acute-phase reactants and disease duration is associated with patient's poor physical mobility.Adaptation of Chinese and English versions of the Ankylosing Spondylitis quality of life (ASQoL) scale for use in SingaporeEarly tumor necrosis factor α antagonist therapy in everyday practice for inflammatory back pain suggesting axial spondyloarthritis: results from a prospective multicenter french cohort.A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis.Prevalence and associated risk factors for work disability in Egyptian patients with ankylosing spondylitis from one center.Ankylosing spondylitis presenting to a chiropractic office: a report of two cases.Gender differences in Iranian patients with ankylosing spondylitis.Which measuring site in ankylosing spondylitis is best to detect bone loss and what predicts the decline: results from a 5-year prospective study.The McMaster Toronto Arthritis patient preference questionnaire (MACTAR): a methodological study of reliability and minimal detectable change after a 6 week-period of acupuncture treatment in patients with rheumatoid arthritis.Translation, cultural adaptation, and validation of the Bath questionnaires and HAQ-S in Hindi for Indian patients with ankylosing spondylitis.
P2860
Q33314436-8CFA7C78-112D-44B8-AAD7-00059487FCFEQ34014598-E771D73C-E766-4A4F-A9B4-C3B76870312EQ34117039-1C671F91-5810-40E0-8321-961DCBD94960Q34222218-A1BF4169-AD5E-49BB-B6C6-7CB80F5741A2Q34507570-255E3800-F5D4-48E8-903B-DC63FD28C34BQ34650355-591E6729-1D53-42EE-9F7A-64FF819CA15FQ35071645-6B0BAE8A-052B-4EF4-804C-9A996AD01581Q35549928-A46E96ED-D9CB-4E28-AB63-6C405BC922A9Q35550292-6B460B75-34E3-4EAD-8693-0D49A890516AQ35551784-C8C18D6B-B4F9-4078-8805-38DF90CA29D4Q35553676-F018A1F7-38E3-47A8-AB92-6C7D3CA53BA5Q35555116-D4C7463F-8130-451C-B3DA-F85C01DFD31EQ35638180-4EE11A98-AB02-4D06-9FF6-8B9E4C5A8220Q35838797-3515AE57-C18A-410C-8C31-67CC05A970AFQ35880376-93F18E29-792E-48AA-9700-26820A27B0DEQ36245947-99819BF7-E666-44EA-AAC6-B3400C8031A3Q36454463-5C81D9FE-4F6F-4470-946E-88978476D2F6Q36992933-43C7B5C3-D832-475F-B82A-E83B094796B8Q37191464-1E4F1C8B-A5E9-4CBF-A5B3-7297EDD14D7EQ37631508-E4FE2B7E-D6E5-4A8B-9064-ACDB31ADBCE0Q38010372-F96222BC-FFE1-44B3-95E9-E61B01602587Q38139808-4CDF544D-E7A9-4CF8-BB68-799C02951740Q38748204-029D8AAC-E650-4C41-80AC-647D6972DF91Q38974892-61BA16D8-9678-498E-944B-9F830A1CC245Q39476642-EFEC77B4-07FB-456C-8F04-E17E613E4B35Q39513524-913F033C-3CBF-464A-A652-D994EB019104Q39954736-BAABE1C0-3E75-44F6-8901-6EA5CD37A0B8Q40401248-7CCD97F1-A90A-469E-8B27-72AF38640972Q40523969-8786554A-4B7D-4B62-A70A-C91FF2E5D249Q40709174-8F3EDB19-3D07-4B7F-85F7-1B75305D3973Q41362640-AB8EFF50-7EB8-478F-851A-886C2BF5B3D0Q41451166-23F1830E-C175-4BE6-9BA2-F3BE113C2DA2Q43527556-24F907E1-ACA7-41B3-9FDE-7ACE68D43067Q43937874-D0EEF827-2954-46B1-AA17-F995463CFDD8Q44077285-1A1DEA6F-796B-4AD6-8846-069510CAF972Q45764344-DFE20FB2-2D8A-4990-BC2D-AA4F80A00858Q45852300-650C2255-0DAE-43BF-9247-5B12B6045443Q47146126-40D1E7C3-A412-4748-A040-BDAA5073529BQ47149814-7BBF1226-58AA-4B4A-A71E-8DA7F47118CDQ47187728-88D3CDF0-E119-4C32-8026-70143B732A16
P2860
The Bath Ankylosing Spondylitis Patient Global Score (BAS-G).
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
The Bath Ankylosing Spondylitis Patient Global Score (BAS-G).
@en
The Bath Ankylosing Spondylitis Patient Global Score
@nl
type
label
The Bath Ankylosing Spondylitis Patient Global Score (BAS-G).
@en
The Bath Ankylosing Spondylitis Patient Global Score
@nl
prefLabel
The Bath Ankylosing Spondylitis Patient Global Score (BAS-G).
@en
The Bath Ankylosing Spondylitis Patient Global Score
@nl
P2093
P356
P1476
The Bath Ankylosing Spondylitis Patient Global Score (BAS-G).
@en
P2093
P356
10.1093/RHEUMATOLOGY/35.1.66
P577
1996-01-01T00:00:00Z